These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7640324)

  • 21. Decreased glutamic acid decarboxylase(67) mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders.
    Thompson M; Weickert CS; Wyatt E; Webster MJ
    J Psychiatr Res; 2009 Jul; 43(11):970-7. PubMed ID: 19321177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
    Takahashi T; Suzuki M; Tanino R; Zhou SY; Hagino H; Niu L; Kawasaki Y; Seto H; Kurachi M
    Psychiatry Res; 2007 Apr; 154(3):209-19. PubMed ID: 17321114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical intercorrelations of frontal area volumes in schizophrenia.
    Mitelman SA; Buchsbaum MS; Brickman AM; Shihabuddin L
    Neuroimage; 2005 Oct; 27(4):753-70. PubMed ID: 15990338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
    Webster MJ; O'Grady J; Kleinman JE; Weickert CS
    Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of regulator of G-protein signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia.
    Bowden NA; Scott RJ; Tooney PA
    Schizophr Res; 2007 Jan; 89(1-3):165-8. PubMed ID: 17071056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia.
    Ghose S; Weickert CS; Colvin SM; Coyle JT; Herman MM; Hyde TM; Kleinman JE
    Neuropsychopharmacology; 2004 Jan; 29(1):117-25. PubMed ID: 14560319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical kindling induced by pentylenetetrazol changes cholecystokinin mRNA and peptide levels in rat frontal cortex.
    Takeda K; Nakata K; Chikuma T; Ito T; Kato T
    Neurosci Lett; 1997 Oct; 234(2-3):115-8. PubMed ID: 9364511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental and regional changes of cholecystokinin mRNA in rat brains.
    Hasegawa M; Usui H; Araki K; Kuwano R; Takahashi Y
    FEBS Lett; 1986 Jan; 194(2):224-6. PubMed ID: 3940896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of CCK binding sites in the human hippocampal formation and their alteration in schizophrenia: a post-mortem autoradiographic study.
    Kerwin R; Robinson P; Stephenson J
    Psychol Med; 1992 Feb; 22(1):37-43. PubMed ID: 1574565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histopathology of the brain in schizophrenia complicated by hypertension and cerebral atherosclerosis. I].
    Zaiko IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(2):284-91. PubMed ID: 6000266
    [No Abstract]   [Full Text] [Related]  

  • 33. Depletion of cortical cholecystokinin levels after excitotoxin injection into the nucleus basalis: sensitivity to MK-801.
    Bandopadhyay R; De Belleroche J
    Eur J Pharmacol; 1995 Feb; 275(1):53-9. PubMed ID: 7774662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects.
    Williamson P; Pelz D; Merskey H; Morrison S; Karlik S; Drost D; Carr T; Conlon P
    Am J Psychiatry; 1992 Apr; 149(4):549-51. PubMed ID: 1554045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electron-microscopic analysis of cytoarchitectonic disorders in the cerebral cortex in schizophrenia].
    Oĭfa AI; Uranova NA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(10):48-52. PubMed ID: 1665652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of expression of an NMDARI splice variant in the superior temporal gyrus in schizophrenia.
    Le Corre S; Harper CG; Lopez P; Ward P; Catts S
    Neuroreport; 2000 Apr; 11(5):983-6. PubMed ID: 10790868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in cholecystokinin peptide and mRNA in actively epileptic human temporal cortical foci.
    Iadarola MJ; Sherwin AL
    Epilepsy Res; 1991; 8(1):58-63. PubMed ID: 2060503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postnatal development of cholecystokinin-like immunoreactivity and its mRNA level in rat brain regions.
    Takeda K; Koshimoto H; Uchiumi F; Haun RS; Dixon JE; Kato T
    J Neurochem; 1989 Sep; 53(3):772-8. PubMed ID: 2760620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain abnormalities in schizophrenia.
    Friedman EH
    J Clin Psychiatry; 1991 Jan; 52(1):43. PubMed ID: 1988421
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of Oct-6, a POU III domain transcription factor, in schizophrenia.
    Ilia M; Beasley C; Meijer D; Kerwin R; Cotter D; Everall I; Price J
    Am J Psychiatry; 2002 Jul; 159(7):1174-82. PubMed ID: 12091196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.